Posted on February 23, 2022
By Jürgen Schrapp | Bayer, Head of R&D Procurement
December 7, 2022
By Ahmed Elhusseiny | Roche Pharmaceuticals, Area Head, Asia Pacific
Much like the healthcare environment in Asia Pacific, Roche is rapidly evolving. We are transforming our organisation to fulfil a bold ambition of delivering more benefit to patients faster by helping to build the efficient, sustainable healthcare systems of the future. A critical part of this process is the development of our talent. We believe […]
January 11, 2022
By Jennifer Snyder | Novartis Pharmaceuticals, Director, Portfolio Strategy Management for Technical Research and Development Cell & Gene Therapy
January 4, 2022
By Rebekah Martin | AstraZeneca, Senior Vice President of Reward and Inclusion
January 24, 2022
By Alexander M. Haydl | Boehringer Ingelheim Germany, Head of Late-Stage Development Laboratory and Product Owner of Digital Process Development
August 31, 2021
By Teresa Foy | Bristol Myers Squibb, Sr Vice President Immuno-Oncology and Cellular Therapy
March 10, 2022
By Elizabeth Jurica | Bristol Myers Squibb, Principal Scientist
January 28, 2022
By Stuart Flanagan | Evotec, Group Leader
June 8, 2021
By Carolyn Carroll | SwanBio Theraputics, Chief People Officer, Winners of 2021 Life Sciences Pennsylvania Emerging Company of the Year
June 16, 2021
By Rajeev Nair | Merck, Senior Vice President & Head of Asia Pacific - Research Solutions
March 7, 2022
By Vijetha Bhat | Lonza, Houston,Texas, Scientist, Research and Development
August 19, 2021
By Galym Dauletbakov | Takeda, Business Operations Head UCC
May 20, 2022
By Jason Rudd | Amgen, Statistical Programming Manager
December 21, 2021
By Kaja Natland | Organon, Regional President, Asia Pacific & Japan
